WHAT WE DO
We use our integrative research process to uncover and leverage the best opportunities in emerging high-growth segments in technology and healthcare for the benefit of the investors and growth companies we serve, as well as our broader society and environment. Integrative research draws heavily on our relationships with companies and unifies naturally divergent perspectives, capabilities, skill sets, and relationships, yielding a deep, comprehensive understanding of each segment's near-term and long-term potential.
Technology / SaaS
Healthcare
Environmental Technology
VENTURE
CAPITAL
First Analysis is a leading venture capital investor, having invested more than $800 million over four decades. Leveraging our integrative research process, we partner with strong teams leading rapid-growth companies to build industry leaders in the targeted sectors where we are acknowledged experts and where success benefits not only our investors, but also our broader society and environment.
INTEGRATIVE
RESEARCH
Integrative research means our extensive company research informs every thesis and perspective. The result is deep industry knowledge, expertise, and trend insights that yield valuable results for our clients and partners.
INVESTMENT
BANKING
Our investment bankers have a wealth of industry knowledge, contacts, and execution expertise to drive strategic transactions with uncompromised loyalty to our clients.
NEWS & INSIGHTS
First Analysis acted as the exclusive financial advisor to sticky.io for its minority equity investment
First Analysis acted as the exclusive financial advisor to sticky.io (formerly LimeLight CRM) for its capital financing led by Flexpoint Ford. The First Analysis team worked closely with sticky.io to understand the industry and create a unit-based economic model while positioning the company optimally in the marketplace.
July 02, 2020
First Analysis acted as the exclusive financial advisor to sticky.io (formerly LimeLight CRM) for its capital financing led by Flexpoint Ford. The First Analysis team worked closely with sticky.io to understand the industry and create a unit-based economic model while positioning the company optimally in the marketplace.
July 02, 2020
First Analysis announces enhanced cutting-edge research focus
As First Analysis approaches its 40th year of using integrative research to uncover and leverage the best opportunities in emerging high-growth segments in technology and healthcare, it is enhancing its research model and increasing its commitment to publishing research on cutting-edge trends in technology and healthcare.
April 22, 2020
As First Analysis approaches its 40th year of using integrative research to uncover and leverage the best opportunities in emerging high-growth segments in technology and healthcare, it is enhancing its research model and increasing its commitment to publishing research on cutting-edge trends in technology and healthcare.
April 22, 2020
First Analysis invests in VIDA, the leader in AI-powered lung imaging analysis
First Analysis, a leading venture capital investor, has made a new investment in VIDA Diagnostics Inc. (VIDA). VIDA provides the new standard of pulmonary care by using AI-powered CT imaging software and services to aid early detection, evaluation, and treatment planning for patients with or at risk of lung diseases. First Analysis led an $11 million initial close of the Series C round to accelerate the commercialization of VIDA’s LungPrint® solution suite.
March 17, 2020
First Analysis, a leading venture capital investor, has made a new investment in VIDA Diagnostics Inc. (VIDA). VIDA provides the new standard of pulmonary care by using AI-powered CT imaging software and services to aid early detection, evaluation, and treatment planning for patients with or at risk of lung diseases. First Analysis led an $11 million initial close of the Series C round to accelerate the commercialization of VIDA’s LungPrint® solution suite.
March 17, 2020
©2020 by First Analysis Corporation.
One South Wacker Drive
  ·  
Suite 3900
  ·  
Chicago, IL 60606
  ·  
312-258-1400